| Authors: |
Cote GM; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Kochupurakkal BS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Do K; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bullock A; Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Cheng ML; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Muzikansky A; Mass General Cancer Center, Boston, Massachusetts., McLoughlin DE; Mass General Cancer Center, Boston, Massachusetts., Cleary JM; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gao X; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Parikh A; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Park JC; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Weekes CD; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Yeku O; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Zou L; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Duke University, Durham, North Carolina., Shapiro GI; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. |